The objective of this study was to assess the spectrum of growth abnormalit
ies in children with 18q deletions. The growth axis of 50 individuals with
a cytogenetically and molecularly confirmed 18q deletion was investigated b
y determining height, growth velocity, insulin-like growth factor I (IGF-I)
, IGF-binding protein-3, bone maturation, and response to pituitary stimula
nts of GH.
Children with 18q deletions are short; 64% have a height more than -2 SD be
low the mean. Affected children also grow slowly; 68% have a growth velocit
y more than -1 SD below the mean. Half of the individuals have delayed bone
maturation. Growth factors are skewed downward; 72% of the IGF-I values an
d 83% of the IGF-binding protein-3 values are below the mean for chronologi
cal age. Similarly, 72% of the children had a reduced or absent response to
either of the the GH stimulants, arginine and clonidine. In the total grou
p of 50 children only 2 were normal for all parameters evaluated.
Short stature and poor growth are common features of individuals with 18q d
eletions. GH deficiency is common in this cohort of patients and probably p
lays a role in the short stature seen in many of the affected individuals.